UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): ~~May~~September 610, 2019

CNL HEALTHCARE PROPERTIES II, INC.

(Exact Name of Registrant as Specified in its Charter)

Maryland

000-55777

47-4524619

(State or other jurisdiction

of incorporation)

(Commission File No.)

(I.R.S. Employer

Identification No.)


450 South Orange Avenue, Orlando, FL		32801
(Address of Principal Executive Offices)		(Zip Code)

Registrant’s telephone number, including area code (407) 650-1000

Not applicable

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☒

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading

Symbol(s)

Name of each exchange

on which registered

None

N/A

~~Item~~ITEM 25.0107 ~~Completion~~SUBMISSION ofOF ~~Acquisition~~MATTERS orTO ~~Disposition~~A ofVOTE ~~Assets.~~OF SECURITY HOLDERS

~~Sale~~On September 10, 2019, CNL Healthcare Properties II, Inc. (the “Company”) held its annual meeting of ~~MOB~~stockholders ~~Property~~(the “Annual Meeting”) at CNL Center at City Commons, Tower I, 13th Floor, 450 South Orange Avenue, Orlando, Florida 32801. At the Annual Meeting, the Company’s stockholders voted in person or by proxy on:

~~As previously~~(1) A ~~reported~~plan inof acomplete ~~Current~~liquidation ~~Report~~and ondissolution ~~Form 8-K filed on March 19, 2019, CHP II Overland Park KS MOB Owner, LLC, an operating subsidiary~~ of ~~CNL~~the ~~Healthcare~~Company ~~Properties II, Inc.~~ (~~referred~~the to“Plan ~~herein~~of ~~as “we~~Dissolution”, ~~“us”,~~and ~~“our” or~~ the ~~“Company”)~~ proposal, (the “~~Seller”),~~Plan ~~entered~~of ~~into~~Dissolution ~~an Asset Purchase Agreement (the “Sale Agreement~~Proposal”). ~~with~~The ~~HCP~~principal ~~Medical~~purpose ~~Office~~of ~~Buildings,~~the ~~LLC,~~Plan aof ~~Delaware~~Dissolution ~~limited~~is ~~liability company~~to ~~(the~~maximize ~~“Original~~stockholder ~~Purchaser”),~~value ~~for~~by ~~the~~selling ~~sale of~~ the Company’s ~~medical~~assets, ~~office~~paying ~~building~~its ~~located~~debts inand ~~Overland~~distributing ~~Park, Kansas (~~the ~~“Property”)~~net ~~for~~proceeds ~~approximately~~from ~~$15.4 million~~liquidation ~~in cash (the “Sale”), subject~~ to ~~certain pro-rations and other adjustments as described in~~ the ~~Sale~~Company’s ~~Agreement~~stockholders.

~~On May 6, 2019, the Seller and Overland Park MOB, LLC, an affiliate of the Original Purchaser consummated the Sale~~ (~~the “Closing Date”~~2), Three ~~which~~proposed ~~resulted~~amendments ~~in net cash proceeds~~ to the Company’s ofcharter ~~approximately $9.5 million after closing costs and repayment of indebtedness secured by the Property sold~~ (~~the~~together, the “~~Sale~~Charter ~~Proceeds~~Amendment Proposals”). ~~The Company intends~~ to: use the remainder of the Sale Proceeds strategically to pay down the Company’s indebtedness on one of its senior housing assets and for other corporate purposes. The Company does not plan to make a special distribution at this time in its strategic alternatives process as it continues to focus on maximizing value for its stockholders. The Company’s remaining real estate portfolio consists of two senior housing properties.

~~Item~~(a) 7eliminate (i) conditions and limitations on the Company’s exculpation and indemnification of the Company’s present or former directors and the Company’s external advisor and its affiliates and (ii) limitations on the Company’s ability to reimburse the Company’s present or former directors and the Company’s external advisor or its affiliates for reasonable legal expenses and other costs, each of which had previously been required by state securities administrators in connection with the Company’s initial public offering or that related to such required provisions.01 ~~Regulation~~Instead, FDthe ~~Disclosure~~proposed amendment provides that the Company shall exculpate and indemnify the Company’s present and former directors and officers to the maximum extent permitted by Maryland law and provides the Company the ability to exculpate and indemnify the Company’s external advisor and its affiliates pursuant to the terms of the advisory agreement (the “Indemnification Proposal”),

~~The~~(b) ~~Company~~eliminate ~~will~~the ~~e-mail~~requirement ~~its~~in ~~stockholders~~the Company’s ~~financial~~charter ~~advisors~~to distribute a ~~letter~~specific ~~and~~report ~~send~~with ~~the~~audited ~~Company’s~~financial statements, related party and other information to stockholders aeach ~~letter~~year, ~~notifying~~that ~~them~~had ofpreviously ~~the~~been ~~closing~~required ofby state securities administrators in connection with the ~~Sale~~Company’s ~~and~~initial ~~advising~~public ofoffering or that related ~~matters~~to such required provisions (the “Reporting Proposal”). AAlthough ~~copy~~the ofcharter would no longer require the ~~letter~~Company to ~~financial~~provide ~~advisors~~audited isfinancial ~~filed~~statements asto ~~Exhibit~~the ~~99.1~~Company’s ~~and~~stockholders, aany ~~copy~~decision ofby the ~~letter~~Company to ~~stockholders~~cease isproviding ~~filed~~audited asfinancial ~~Exhibit~~statements ~~99.2~~ to ~~this~~the ~~Current~~Company’s ~~Report~~stockholders onwould ~~Form~~need ~~8-K~~to be approved by the board of directors and iswould ~~incorporated~~require ~~herein~~that bythe ~~reference~~Securities ~~solely~~and ~~for~~Exchange Committee grant the ~~purposes~~Company ofrelief ~~this~~from ~~Item~~certain ~~7.01~~reporting ~~disclosure~~requirements under the U.S. Securities Exchange Act of 1934, as amended, and

~~Pursuant~~(c) toexclude the ~~rules~~distribution ~~and regulations~~ of ~~the~~interests ~~Securities and Exchange Commission (the “SEC”), the information contained~~ in ~~this~~a ~~Item 7.01~~liquidating ~~disclosure,~~trust ~~including~~from ~~Exhibits 99.1 and 99.2 and~~ the ~~information~~definition ~~set~~of ~~forth therein, is deemed to have been furnished and shall not be deemed to be~~ a “~~filed~~roll-up transaction” ~~under the Securities Exchange Act of 1934, as amended~~ (the “~~Exchange Act~~Roll-Up Definition Proposal”),; or otherwise subject to the liabilities of such section, nor shall any of such information be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

By(3) The ~~furnishing~~election of the ~~information~~following ~~contained~~individuals into ~~this~~the ~~Item~~board ~~7.01~~of ~~disclosure,~~directors: ~~including Exhibits~~Stephen 99H.1 ~~and 99.2~~Mauldin, ~~the~~Douglas ~~Company~~N. ~~makes~~Benham, noand Dianna ~~admission~~F. ~~as to the materiality of such information~~Morgan.

~~Item~~(4) The ~~9.01~~ratification ~~Financial~~of ~~Statements~~the appointment of Ernst & Young LLP (“E&Y”) as the Company’s independent registered public accounting firm for the year ended December 31, 2019; and ~~Exhibits~~

(5) A proposal that would permit the Company (a) to proceed with the voting on and approval of only the proposals that have received sufficient votes to be approved at the Annual Meeting, and (b) subsequently, ~~Pro~~to ~~forma~~adjourn ~~financial~~the ~~information~~Annual Meeting, even if a quorum is present, to solicit additional proxies to vote in favor of any proposal that had not received sufficient votes to be approved at the Annual Meeting, if necessary (the “Adjournment Proposal”).

~~The~~For ~~following~~a ~~unaudited~~detailed ~~pro~~description ~~forma~~of each ~~consolidated~~of ~~financial~~the ~~statements~~proposals ~~have~~submitted ~~been~~for ~~prepared~~stockholder tovote ~~provide~~at ~~pro~~the ~~forma~~Annual ~~information~~Meeting, ~~with~~including ~~regards~~a summary of the Plan of Dissolution Proposal and the revisions that each of the Charter Amendment Proposals would make to athe ~~real~~Company’s previous charter, see ~~estate~~the ~~disposition~~Company’s Definitive Proxy Statement, ~~described~~filed inwith ~~Item~~the ~~2.01~~Securities ~~above~~and Exchange Commission on July 7, 2019 (the “Proxy Statement”).

The ~~accompanying~~Plan ~~unaudited~~of ~~pro~~Dissolution ~~forma~~Proposal ~~condensed~~was ~~consolidated~~approved. ~~balance~~The ~~sheet~~number of ~~the Company~~votes ~~illustrates~~cast ~~the~~for ~~estimated~~and ~~effect~~votes ofwithheld ~~the Sale~~from, ~~described~~and inthe ~~described~~number inof ~~Item~~abstentions ~~2.01~~and ~~above,~~broker asnon-votes ifwith itrespect ~~had~~to, ~~occurred~~the asPlan of ~~December~~Dissolution ~~31,~~Proposal ~~2018.~~were as follows:

The accompanying unaudited pro forma condensed consolidated statements of operations of the Company are presented for the years ended December 31, 2018 and 2017 (the “Pro Forma Periods”) and include certain pro forma adjustments to illustrate the estimated effect of the Sale, described in Item 2.01 above, as if it had occurred on January 1, 2017, which represents the first day of the first pro forma period presented.


	Votes For		Votes Against		Abstentions		Broker Non-Votes
Plan of Dissolution Proposal		2,891,365		81,175		41,590		1,133,789

~~This~~Two ~~unaudited pro forma condensed consolidated financial information is presented for informational purposes only and does not purport to be indicative~~ of the ~~Company’s~~three ~~financial~~Charter ~~position~~Amendment orProposals, ~~financial results as if~~ the ~~transaction~~Reporting ~~reflected~~Proposal ~~herein~~and ~~had occurred as of~~ the ~~date~~Roll-Up ~~indicated~~Definition orProposal, ~~been~~were ~~in effect during the Pro Forma Periods~~approved. InThe ~~addition,~~Indemnification ~~this~~Proposal ~~unaudited~~was ~~pro forma condensed consolidated financial information should~~ not beapproved. ~~viewed~~The asamendments ~~indicative~~to of the Company’s ~~expected~~charter ~~financial~~were ~~position~~filed orin ~~financial~~Maryland ~~results~~and ~~for~~became ~~future~~effective ~~periods~~on ~~and~~September 10, ~~should~~2019. ~~be read in~~The ~~conjunction~~number ~~with~~of ~~the~~votes ~~Company’s~~cast ~~financial~~for ~~statements~~and asvotes ~~filed~~withheld infrom, and the ~~Company’s~~number ~~Annual~~of ~~Report~~abstentions onand ~~Form~~broker 10non-Kvotes ~~for~~with respect to, the ~~year~~three ~~ended~~Charter ~~December~~Amendment ~~31,~~Proposals ~~2018.~~were as follows:

CNL HEALTHCARE PROPERTIES II, INC. AND SUBSIDIARIES


	Votes For		Votes Against		Abstentions		Broker Non-Votes
Indemnification Proposal		2,456,415		386,699		171,016		1,133,789
Reporting Proposal		2,575,351		337,300		101,479		1,133,789
Roll-Up Definition Proposal		2,664,838		239,281		110,011		1,133,789

~~PRO~~All ~~FORMA~~of ~~CONDENSED~~the ~~CONSOLIDATED~~director ~~BALANCE~~nominees ~~SHEET~~were ~~(UNAUDITED)~~elected. The number of votes cast for and votes withheld from each of the director nominees and the number of broker non-votes were as follows:

AS OF DECEMBER 31, 2018


Name	Votes For		Votes Withheld		Broker Non-Votes
Stephen H. Mauldin		2,847,494		166,636		1,133,789
Douglas N. Benham		2,853,494		160,636		1,133,789
Dianna F. Morgan		2,859,891		154,239		1,133,789

ASSETS	CHP IIHistorical			MOB SalePro FormaAdjustments				CHP IIPro Forma
Real estate investment properties, net	$	53,573,013		$	(10,603,833	)	(a)	$	42,969,180
Cash		8,003,576			15,359,500		(a)		17,753,578
					(5,609,498	)	(b)
Intangibles, net		4,983,627			(3,485,818	)	(a)		1,497,809
Other assets		495,188			(112,551	)	(a)		382,637
Restricted cash		233,971			—				233,971
Total assets	$	67,289,375		$	(4,452,200	)		$	62,837,175
LIABILITIES AND STOCKHOLDERS’ EQUITY
Liabilities:
Mortgages and notes payable, net	$	24,197,359		$	(5,600,000	)	(b)	$	18,665,013
					67,654		(a)
Accounts payable and accrued liabilities		888,816			(382,237	)	(a)		497,081
					(9,498	)	(b)
Others liabilities		452,063			(323,106	)	(a)		128,957
Due to related parties		85,902			—				85,902
Total liabilities		25,624,140			(6,247,187	)			19,376,953
Stockholders’ equity:
Preferred stock, $0.01 par value per share, 10,000,000 shares authorized; none issued or outstanding		—			—				—
Class A Common stock, $0.01 par value per share, 1,200,000,000 shares authorized; 4,899,139 shares issued and outstanding as of December 31, 2018		48,995			—				48,995
Capital in excess of par value		48,039,220			—				48,039,220
Accumulated loss		(3,464,160	)		1,794,987		(a)		(1,669,173	)
Accumulated distributions		(2,958,820	)		—				(2,958,820	)
Total stockholders’ equity		41,665,235			1,794,987				43,460,222
Total liabilities and stockholders’ equity	$	67,289,375		$	(4,452,200	)		$	62,837,175

The appointment of E&Y was ratified. The number of votes cast for and votes withheld from, and the number of abstentions with respect to, the ratification of the appointment of E&Y as the Company’s independent registered public accounting firm for the year ended December 31, 2019 were as follows:

See accompanying notes to pro forma condensed consolidated financial statements.


	Votes For		Votes Against		Abstentions		Broker Non-Votes
Ratification of E&Y Appointment		4,038,075		61,412		48,432		—

~~CNL~~The ~~HEALTHCARE~~Adjournment ~~PROPERTIES~~Proposal ~~II,~~was ~~INC~~approved. ~~AND~~The ~~SUBSIDIARIES~~number of votes cast for and votes withheld from, and the number of abstentions with respect to, the Adjournment Proposal were as follows:

PRO FORMA CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS (UNAUDITED)


	Votes For		Votes Against		Abstentions		Broker Non-Votes
Adjournment Proposal		2,793,505		167,908		52,717		1,133,789

~~FOR~~ITEM ~~THE~~9.01 ~~YEAR~~FINANCIAL ~~ENDED~~STATEMENTS ~~DECEMBER 31,~~AND ~~2018~~ EXHIBITS

	CHP IIHistorical			MOB SalePro FormaAdjustments				CHP II ProForma
Ex.	Description
Revenues:
99.1	Articles of Amendment
Resident fees and services	$	5,905,098		$	—			$	5,905,098
Rental income and tenant reimbursements		1,532,218			(1,532,218	)	(a)		—
Total revenues		7,437,316			(1,532,218	)			5,905,098
Operating expenses:
Property operating expenses		4,230,905			(599,694	)	(a)		3,631,211
General and administrative		1,211,915			—				1,211,915
Property management fees		381,465			(44,989	)	(a)		336,476
Depreciation and amortization		2,304,728			(524,943	)	(a)		1,779,785
Acquisition fees and expenses		818			—				818
Total operating expenses		8,129,831			(1,169,626	)			6,960,205
Operating loss		(692,515	)		(362,592	)			(1,055,107	)
Other income (expense):
Interest and other income		15,819			—				15,819
Interest expense and loan cost amortization		(1,127,693	)		274,164		(a)		(853,529	)
Total other expense		(1,111,874	)		274,164				(837,710	)
Loss before income taxes		(1,804,389	)		(88,428	)			(1,892,817	)
Income tax expense		794			—				794
Net loss	$	(1,805,183	)	$	(88,428	)		$	(1,893,611	)
Class A Common Stock (basic and diluted):
Net loss attributable to Class A stockholders	$	(661,345	)					$	(693,742	)
Net loss per share of Class A common stock outstanding	$	(0.43	)					$	(0.45	)
Weighted average number of Class A common shares outstanding (b)		1,547,449							1,547,449
Class T Common Stock (basic and diluted):
Net loss attributable to Class T stockholders	$	(1,025,147	)					$	(1,075,365	)
Net loss per share of Class T common stock outstanding	$	(0.43	)					$	(0.45	)
Weighted average number of Class T common shares outstanding (b)		2,398,691							2,398,691
Class I Common Stock (basic and diluted):
Net loss attributable to Class I stockholders	$	(118,691	)					$	(124,504	)
Net loss per share of Class I common stock outstanding	$	(0.43	)					$	(0.45	)
Weighted average number of Class I common shares outstanding (b)		277,718							277,718

See accompanying notes to pro forma condensed consolidated financial statements.

CNL HEALTHCARE PROPERTIES II, INC. AND SUBSIDIARIES

PRO FORMA CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS (UNAUDITED)

FOR THE YEAR ENDED DECEMBER 31, 2017

	CHP IIHistorical			MOB SalePro FormaAdjustments					CHP IIPro Forma
Revenues:
Resident fees and services	$	3,290,191		$	—				$	3,290,191
Rental income and tenant reimbursements		18,624			(18,624	)	(a	)		—
Total revenues		3,308,815			(18,624	)				3,290,191
Operating expenses:
Property operating expenses		1,852,057			(4,400	)	(a	)		1,847,657
General and administrative		917,700			—					917,700
Property management fees		196,632			—					196,632
Depreciation and amortization		971,389			—					971,389
Total operating expenses		3,937,778			(4,400	)				3,933,378
Operating loss		(628,963	)		(14,224	)				(643,187	)
Other income (expense):
Interest and other income		66			(44	)	(a	)		22
Interest expense and loan cost amortization		(589,540	)		—					(589,540	)
Total other expense		(589,474	)		(44	)				(589,518	)
Loss before income taxes		(1,218,437	)		(14,268	)				(1,232,705	)
Income tax expense		98,093			—					98,093
Net loss	$	(1,316,530	)	$	(14,268	)			$	(1,330,798	)
Class A Common Stock (basic and diluted):
Net loss attributable to Class A stockholders	$	(438,710	)						$	(443,465	)
Net loss per share of Class A common stock outstanding	$	(0.74	)						$	(0.75	)
Weighted average number of Class A common shares outstanding (b)		590,225								590,225
Class T Common Stock (basic and diluted):
Net loss attributable to Class T stockholders	$	(833,933	)						$	(842,970	)
Net loss per share of Class T common stock outstanding	$	(0.74	)						$	(0.75	)
Weighted average number of Class T common shares outstanding (b)		1,121,944								1,121,944
Class I Common Stock (basic and diluted):
Net loss attributable to Class I stockholders	$	(43,887	)						$	(44,363	)
Net loss per share of Class I common stock outstanding	$	(0.74	)						$	(0.75	)
Weighted average number of Class I common shares outstanding (b)		59,044								59,044

See accompanying notes to pro forma condensed consolidated financial statements.

CNL HEALTHCARE PROPERTIES II, INC. AND SUBSIDIARIES

NOTES TO PRO FORMA CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

1. Basis of Presentation

The accompanying unaudited pro forma condensed consolidated balance sheet of the Company illustrates the estimated effect of the disposition, described in Note 2. “Pro Forma Transaction,” as if it had occurred as of December 31, 2018. The accompanying unaudited pro forma consolidated statements of operations of the Company are presented for the years ended December 31, 2018 and 2017, and include certain pro forma adjustments to illustrate the estimated effect of the Company’s disposition, described in Note 2. “Pro Forma Transaction,” as if it had occurred on January 1, 2017, which represents the first day of the first pro forma period presented. The amounts included in the historical columns represent the Company’s historical balance sheet and operating results for the respective Pro Forma Periods presented as filed with the Securities and Exchange Commission.

The accompanying unaudited pro forma condensed consolidated financial statements have been prepared in accordance with Article 11 of Regulation S-X and do not include all of the information and note disclosures required by generally accepted accounting principles of the United States (“GAAP”). Pro forma financial information is intended to provide information about the continuing impact of a transaction by showing how a specific transaction or group of transactions might have affected historical financial statements. Pro forma financial information illustrates only the isolated and objectively measurable (based on historically determined amounts) effects of a particular transaction, and excludes effects based on judgmental estimates of how historical management practices and operating decisions may or may not have changed as a result of the transaction. Therefore, pro forma financial information does not include information about the possible or expected impact of current actions taken by management in response to the pro forma transaction, as if management’s actions were carried out in previous reporting periods.

This pro forma condensed consolidated financial information is presented for informational purposes only and does not purport to be indicative of the Company’s financial position or financial results as if the transaction reflected herein had occurred, or been in effect during the Pro Forma Periods. In addition, this pro forma condensed consolidated financial information should not be viewed as indicative of the Company’s expected financial position or financial results for future periods and should be read in conjunction with the Company’s financial statements as filed in the Company’s Annual Report on Form 10-K for the year ended December 31, 2018.

2. Pro Forma Transaction

In March 2019, the Company entered into an asset purchase agreement (“Sale Agreement”) with HCP Medical Office Buildings, LLC related to the sale of Mid America Surgery Institute for a gross sales price of $15.4 million (“MOB Sale”), subject to certain pro-rations and other adjustments as described in the Sale Agreement.

On May 6, 2019, the Company completed the MOB Sale to an affiliate of HCP Medical Office Buildings, LLC.

3. Adjustments to Unaudited Pro Forma Condensed Consolidated Balance Sheet

Adjustments to the Unaudited Pro Forma Condensed Consolidated Balance Sheet were needed in order to present the Company’s historical balance sheet as if the MOB Sale had occurred as of December 31, 2018.

(a) These adjustments reflect the net sales proceeds received from the MOB Sale and the elimination of certain account balances relating to Mid America Surgery Institute as if the MOB Sale had occurred as of December 31, 2018. Accumulated loss has been adjusted to reflect the pro forma gain recognized on the MOB Sale, which is calculated as follows:

Gross sales price	$	15,400,000
Closing and transaction costs		(40,500	)
Net sales proceeds		15,359,500
Less: carrying value of assets		(14,202,202	)
Less: carrying value of unamortized loan costs		(67,654	)
Plus: carrying value of liabilities		705,343
Pro forma gain on sale of real estate	$	1,794,987

(b) These adjustments reflect the portion of net cash proceeds from the MOB Sale used to pay down the related mortgage loan, including accrued interest:

Mortgage loan	$	(5,600,000	)
Accrued interest		(9,498	)
	$	(5,609,498	)

4. Adjustments to Unaudited Pro Forma Condensed Consolidated Statement of Operations

Adjustments to the Unaudited Pro Forma Condensed Consolidated Statements of Operations were needed in order to present the Company’s historical financial results as if the MOB Sale had occurred on January 1, 2017, which represents the first day of the first pro forma period presented.

(a) These adjustments reflect the elimination of the operations relating to Mid America Surgery Institute from the historical financial results for the years ended December 31, 2018 and 2017 to reflect the MOB Sale as if the disposition had occurred on the first day of the Pro Forma Periods presented.

(b) For the purposes of determining the weighted average number of shares of common stock outstanding, stock dividends are treated as if such shares were outstanding as of July 11, 2016 (the date when the Company commenced operations).

(d) Exhibits

99.1		Correspondence with financial advisors of stockholders of CNL Healthcare Properties II, Inc.
99.2		Correspondence with stockholders of CNL Healthcare Properties II, Inc. dated May 6, 2019.

Caution Concerning Forward-Looking Statements

Certain statements in this document may constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”) and of Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). The Company intends that all such forward-looking statements be covered by the safe-harbor provisions for forward-looking statements of Section 27A of the Securities Act and Section 21E of the Exchange Act, as applicable.

All statements, other than statements that relate solely to historical facts, including, among others, statements regarding the Company’s future financial position, business strategy, projected levels of growth, projected costs and projected financing needs, are forward-looking statements. Those statements include statements regarding the intent, belief or current expectations of the management team, as well as the assumptions on which such statements are based, and generally are identified by the use of words such as “may,” “will,” “seeks,” “anticipates,” “believes,” “estimates,” “expects,” “plans,” “intends,” “should,” “continues,” “pro forma” or similar expressions. Forward-looking statements are not guarantees of future performance and actual results may differ materially from those contemplated by such forward-looking statements due to a variety of risks, uncertainties and other factors, including but not limited to, the factors detailed in our annual report for the year ended December 31, 2018, and other documents filed from time to time with the Securities and Exchange Commission.

Many of these factors are beyond the Company’s ability to control or predict. Such factors include, but are not limited to: changes in general economic conditions in the U.S. or globally (including financial market fluctuations); risks associated with our investment strategy; risks associated with the real estate markets in which the Company invests; risks associated with the use of debt to finance the Company’s business activities, including refinancing and interest rate risk and the Company’s failure to comply with its debt covenants; the Company’s failure to obtain, renew or extend necessary financing or to access the debt or equity markets; competition for properties and/or tenants in the markets in which the Company engages in business; the impact of current and future environmental, zoning and other governmental regulations affecting the Company’s properties; the Company’s ability to make necessary improvements to properties on a timely or cost-efficient basis; risks related to development projects or acquired property value-add conversions, if applicable (including construction delays, cost overruns, the Company’s inability to obtain necessary permits and/or public opposition to these activities); defaults on or non-renewal of leases by tenants; failure to lease properties at all or on favorable rents and terms; unknown liabilities in connection with acquired properties or liabilities caused by property managers or operators; the Company’s failure to successfully manage growth or integrate acquired properties and operations; increases in operating costs and other expense items and costs, uninsured losses or losses in excess of the Company’s insurance coverage; the impact of outstanding or potential litigation; risks associated with the Company’s tax structuring; the Company’s failure to qualify and maintain its status as a real estate investment trust; and the Company’s ability to protect its intellectual property and the value of its brands.

Management believes these forward-looking statements are reasonable; however, such statements are necessarily dependent on assumptions, data or methods that may be incorrect or imprecise and the Company may not be able to realize them. Investors are cautioned not to place undue reliance on any forward-looking statements which are based on current expectations. All written and oral forward-looking statements attributable to the Company or persons acting on its behalf are qualified in their entirety by these cautionary statements. Further, forward-looking statements speak only as of the date they are made and the Company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results over time unless otherwise required by law.

For further information regarding risks and uncertainties associated with our business, please refer to the “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and “Risk Factors” sections of our documents filed from time to time with the U.S. Securities and Exchange Commission, including, but not limited to, our annual report on Form 10-K and quarterly reports on Form 10-Q, copies of which may be obtained from our website at http://www.cnlhealthcarepropertiesII.com.

We undertake no obligation to publicly release the results of any revisions to these forward looking-statements that may be made to reflect future events or circumstances or to reflect the occurrence of unanticipated events.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	CNL Healthcare Properties II, Inc.
May 7, 2019	By:	/s/ Stephen H. Mauldin
September 11, 2019	By:	/s/ Ixchell C. Duarte
		Stephen H. Mauldin Chief Executive Officer, President and Chairman
		Ixchell C. Duarte Chief Financial Officer, Treasurer and Senior Vice President

Filing Compare · CNL Healthcare Properties II, Inc.